253 related articles for article (PubMed ID: 30090010)
21. Hybrid Therapy as First-Line Regimen for Helicobacter pylori Eradication in Populations with High Antibiotic Resistance Rates.
Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y
Helicobacter; 2016 Oct; 21(5):382-8. PubMed ID: 26809022
[TBL] [Abstract][Full Text] [Related]
22. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
23. Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Jul; 21(26):8132-9. PubMed ID: 26185386
[TBL] [Abstract][Full Text] [Related]
24. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.
Luther J; Higgins PD; Schoenfeld PS; Moayyedi P; Vakil N; Chey WD
Am J Gastroenterol; 2010 Jan; 105(1):65-73. PubMed ID: 19755966
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(16):5032-8. PubMed ID: 25945019
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori eradication with high-dose proton pump inhibitor-amoxicillin dual therapy: A systematic review and meta-analysis.
Yeh JA; Huang HK; Chou AL; Lin HJ; Feng CL; Kuo CJ; Lai CH
Int J Antimicrob Agents; 2024 Jun; 63(6):107159. PubMed ID: 38554984
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy: a meta-analysis of randomized clinical trials.
Zhang M; Pang M; Zhang M
Clinics (Sao Paulo); 2022; 77():100058. PubMed ID: 35810638
[TBL] [Abstract][Full Text] [Related]
28. Minocycline in the eradication of
Zhou K; Li CL; Zhang H; Suo BJ; Zhang YX; Ren XL; Wang YX; Mi CM; Ma LL; Zhou LY; Tian XL; Song ZQ
World J Gastroenterol; 2024 May; 30(17):2354-2368. PubMed ID: 38813048
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study.
Liang X; Xu X; Zheng Q; Zhang W; Sun Q; Liu W; Xiao S; Lu H
Clin Gastroenterol Hepatol; 2013 Jul; 11(7):802-7.e1. PubMed ID: 23376004
[TBL] [Abstract][Full Text] [Related]
30. Seven-day quintuple regimen as a rescue therapy for Helicobacter pylori eradication.
Mansour-Ghanaei F; Joukar F; Naghipour MR; Forouhari A; Saadat SM
World J Gastroenterol; 2015 Jan; 21(2):661-6. PubMed ID: 25593496
[TBL] [Abstract][Full Text] [Related]
31. Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.
Ye CL; Liao GP; He S; Pan YN; Kang YB; Zhang ZY
Pharmacoepidemiol Drug Saf; 2014 May; 23(5):443-55. PubMed ID: 24677603
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness and safety of vonoprazan-based regimen for Helicobacter pylori eradication: A meta-analysis of randomized clinical trials.
Yang C; Li S; Huang T; Lin H; Jiang Z; He Y; Yuan J; An H
J Clin Pharm Ther; 2022 Jul; 47(7):897-904. PubMed ID: 35247003
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?
Yoon H; Lee DH; Kim N; Park YS; Shin CM; Kang KK; Oh DH; Jang DK; Chung JW
J Gastroenterol Hepatol; 2013 Dec; 28(12):1801-9. PubMed ID: 24118110
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
Sugimoto M; Uotani T; Sahara S; Ichikawa H; Yamade M; Sugimoto K; Furuta T
Helicobacter; 2014 Aug; 19(4):312-8. PubMed ID: 24690010
[TBL] [Abstract][Full Text] [Related]
35. Review article: bismuth-based therapy for Helicobacter pylori eradication in children.
Pacifico L; Osborn JF; Anania C; Vaira D; Olivero E; Chiesa C
Aliment Pharmacol Ther; 2012 May; 35(9):1010-26. PubMed ID: 22404517
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of moxifloxacin-based triple therapy in treatment of Helicobacter pylori infection: a systematic review and meta-analysis of randomized clinical trials.
Zhang G; Zou J; Liu F; Bao Z; Dong F; Huang Y; Yin S
Braz J Med Biol Res; 2013 Jul; 46(7):607-13. PubMed ID: 23903685
[TBL] [Abstract][Full Text] [Related]
37. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
Zhang MM; Qian W; Qin YY; He J; Zhou YH
World J Gastroenterol; 2015 Apr; 21(14):4345-57. PubMed ID: 25892886
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Sep; 21(35):10234-41. PubMed ID: 26401089
[TBL] [Abstract][Full Text] [Related]
39. Nitrofuran-based regimens for the eradication of Helicobacter pylori infection.
Buzás GM; Józan J
J Gastroenterol Hepatol; 2007 Oct; 22(10):1571-81. PubMed ID: 17845685
[TBL] [Abstract][Full Text] [Related]
40. 10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy.
Mori H; Suzuki H; Matsuzaki J; Masaoka T; Kanai T
Digestion; 2020; 101(5):644-650. PubMed ID: 31387107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
